Fighting viruses with donor cells: new hope for transplant patients
NCT ID NCT03665675
Summary
This early-phase study is testing whether specially prepared immune cells from a donor can safely help fight two specific viruses (CMV or adenovirus) in people who have had a stem cell or organ transplant. The treatment is for patients whose infections aren't responding well to standard antiviral medications. Researchers will give these 'virus-fighting' cells to about 20 participants and closely monitor their safety and how well the viruses are controlled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION RECIPIENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nationwide Children's Hospital
RECRUITINGColumbus, Ohio, 43205, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ohio State University Comprehensive Cancer Center
SUSPENDEDColumbus, Ohio, 43210, United States
Conditions
Explore the condition pages connected to this study.